- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- No more ‘old school’: How Duke Health is reimagining workforce development
- Why private practice dentistry needs a better model
- Chief nurses: Hospital finances improve with nursing investments
- Mississippi health system goes ‘all in’ on Epic with $115M investment
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Ascension Wisconsin CEO to step down
- The hospitals, health systems cutting jobs in 2026
- Nonprofit highlights rural opioid care strategies
- The 7 things on the table in the Mount Sinai-Anthem negotiations
- Wearables data predicts patient engagement: Mayo Clinic study
- Advocate plans largest US hospital drone delivery network
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- Indiana system opens $21.7M outpatient center
- Trump administration targets medical school admissions: 4 notes
- EyeSouth Partners continues 2026 expansion with Louisiana practice
- RSV lingers in parts of US even as flu and COVID-19 recede
- A huge month for CMS policy
- What the Health? From KFF Health News: A Headless CDC
- GI is exploding with new tech—but how do patients feel about it?
- Maryland physician to pay $500K+ to settle false claims allegations
- Rhode Island oral surgeon launches Congressional campaign
- Premier Anesthesia, City of Hope Phoenix ink partnership
- 20 behavioral health leaders challenge industry assumptions
- What simulation training revealed about GI skills gaps
- Judge dismisses physician’s wrongful termination suit against staffing firm
- 3 California behavioral health centers to close amid funding shifts
- North Carolina practice to close after 40+ years
- St. Tammany opens outpatient cardiology center
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- 6 dental practice openings to know
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- APRNs, PAs account for most antipsychotic prescriptions for Medicare Part D: Study
- Infosys to acquire Optimum Healthcare IT in $465M deal
- Oklahoma House passes bill expanding scope of dental assistants
- Dr. Nellie Kim-Weroha joins American Association of Orthodontists’ Board of Trustees
- California behavioral health agency to close 2 centers
- 52 DSOs to know: 2026
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- California peer-run behavioral health center to close amid funding shift
- Remarks at the Financial Stability Oversight Council Meeting
- ‘Integration only works if data lives in the same system’: How 5 systems are operationalizing behavioral health
- Inside UHS’ playbook for responsible behavioral health growth
- Epic4 Specialty Partners adds Illinois practice
- The unsolved problems still plaguing dentistry
- American Dental Association adds mental health, GLP-1 prompts to patient forms
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Lilly to remove certain insulin products from European markets by 2027
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- WuXi Bio's record number of new projects in 2025 leaned heavily on US clients
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos
- Gilead inks Manta pact to dive deeper into cancer patient support
- Cheap Children's Clothing Tainted With Lead, Study Says
- Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds
- New Fathers Face Mental Health Challenges, Study Finds
- Your Choice Of Booze Influences Your Risk Of Death, Study Says
- AI Gets a 'D' When Judging Scientific, Medical Claims
- New Online Tool Helps Parkinson's Patients Weigh Brain Implant Decision
- AI chatbot use for health information up 16% from 2024: Rock Health survey
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids
- Wilmington PharmaTech commits $50M to US API expansion
- Strides recalls nearly 90K bottles of children's ibuprofen after contamination complaints
- Trump administration unveils national policy framework for AI as it moves to override state laws
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- 17 spine surgery firsts in Q1
- 17 spine surgery firsts in Q1
- Cencora acquiring EyeSouth Partners' retina business for $1.1B
- A look at how Optum Rx is using AI to address pharmacy fraud, waste and abuse
- Nursing Homes Accused of False Diagnoses To Hide Drug Use
- FDA Approves Higher-Dose Wegovy To Help People Lose More Weight
- Teens Often Pressured To Send Sexual Photos by Someone They Know, Study Finds
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- Rural Residents Have Highest Cancer Death Rates, Researchers Say
- Your Bank Account Might Show How Well Your Brain Will Age, Researchers Say
The New York Post reported yesterday on four U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) audits of state run Medicaid Applied Behavior Analysis for Children Diagnosed With Autism programs. Two of the programs whose audits were reported are contiguous to Michigan: Indiana and Wisconsin. No indication if or when the MDHHS ABA program will be audited by the Feds. Michigan-based Centria Healthcare LLC has distributed over half a billion in Medicaid reimbursements:
https://oig.hhs.gov/reports/work-plan/browse-work-plan-projects/srs-a-25-029/
HHS finds up to $600m ‘improper’ payments for autism services, errors on every bill checked in four states
By Chadwick Moore - March 3, 2026It’s not just Minnesota where people have bilked Medicaid for millions.
Federal auditors found $198 million “improper payments” for Medicaid-funded autism services in four states, and another $410 million may have been incorrectly billed.
The Department of Health and Human Services (HHS) put Medicaid spending for autism care in Indiana, Wisconsin, Maine and Colorado under the microscope, examining 100 monthly bills in each state over a year.
They found potential payment errors in every single one.
According to the audits, Indiana made at least $56 million in improper payouts, Wisconsin $18.5 million, Maine $45.6 million and Colorado a whopping $77.8 million.
Between 2019 and 2025, Medicaid spending on Applied Behavior Analysis (ABA) therapy—the primary treatment protocol for children with autism—has skyrocketed 298% nationwide, according to a report from healthcare analytics company Trilliant Health.
Tatsiana – stock.adobe.comIn 2014, new federal rules required Medicaid to cover autism care. Since then, Autism spectrum disorder (ASD) prevalence in the United States has nearly doubled, from about one in 64 children in 2014 to one in 36 in 2020, with much of the rise attributed to changing diagnostic criteria, increased screening, and greater public awareness.
Payments should not have been made due to reasons like caregivers failed to properly document therapy sessions, lacked the appropriate credentials to provide treatment or patients had not been properly diagnosed with autism.
In addition, in each case the audits flagged separate “potentially improper payments” in each state, which was a much higher number: up to $77 million in Indiana, $22 million in Maine, $94 million in Wisconsin and $207 million in Colorado.
These payments were flagged as carers billing for potential non-therapy time and during recreational activities and not keeping proper notes of the care.
“There’s a big myth that needs to be busted, is the idea that states and the federal government equally share the goal of reducing improper spending,” Chris Medrano, an analyst at the free-market health care research group Paragon Health, told The Post.
He also claimed “a lot” of states use “funding gimmicks” to redirect boatloads of Medicaid money into their general funds, suggesting they may be incentivized to keep the gravy train flowing and turn a blind eye to overbilling.
Although no companies have been prosecuted for fraud related to the HHS audits at this time, the federal government has requested the return of millions of dollars in improper payments from each of the states.
More children are being diagnosed with autism in the US, largely due to increased screening, greater public awareness and a widening of the definition on what counts as autism. Key revisions in 2013 merged previously separate diagnoses into a single Autism Spectrum Disorder (ASD) umbrella.
Feds found “improper or potentially improper” payments in 100 percent of Medicaid-funded autism services sampled across four states in recently published findings—totaling up to $198 million in potentially fraudulent payouts.
Diagnosis rates have gone from 1 in 150 children in 2000 to 1 in 31 children in 2022, according to the CDC.
Some autism researchers, however, have criticized the supposed “epidemic” in autism by suggesting that the new broad criteria has contributed to overdiagnosis.
In 2014, new federal rules required Medicaid to cover autism care. Since then, Medicaid spending on Applied Behavior Analysis (ABA) therapy — the primary treatment protocol for children with autism — has skyrocketed 298% nationwide from seven million hours of therapy administered to 25 million a year in 2024, according to a report from healthcare analytics company Trilliant Health.
Centria Healthcare was the largest Medicaid funded autism care center in the nation, with operations in 12 states as rates of autism diagnoses have exploded since 2014.
As our graph charts, In Indiana, ABA spending rose from $21 million in 2017 to $611 million in 2023 and is projected to reach $825 million by 2029.
North Carolina ABA spending grew from $122 million in 2022 to $329 million by 2024. It is projected to reach an eye-popping $639 million this year.
ABA spending in Nebraska surged from $4.6 million in 2020 to over $83 million in 2024. One provider, Above and Beyond ABA, billed for $29 million alone, according to a state report (it is not suggested they were part of the overbilling).
Colorado ABA payments were $60 million in 2019 and, and $164 million by 2023.
Brown University researcher Daniel Arnold told The Post: “The increases you’re seeing in some states are astronomical […] When private equity comes in usually the price increases, the intensity of services increase as well. In the ABA space this would mean more hours at a higher price.”
However, none has been more eyepopping than Minnesota which received just over $1 million in Medicaid reimbursements for autism care in 2017, but by 2024 that number had skyrocketed to $343 million, according to the Minnesota Department of Human Resources.
As part of numerous federal prosecutions centered around the Somali community in Minneapolis, in September Asha Farhan Hassan and Abdinajib Hassan Yussuf both pleaded guilty to an autism fraud scheme in Minnesota. Hassan owned Smart Therapy Center and was found to have hired unqualified staff, paid kickbacks of $300–$1,500 per month to parents to recruit children — some not diagnosed with autism — billed for services not provided or inflated hours, and submitted false documentation between 2019 and 2024, according to the Department of Justice.
With all the money sloshing around, private equity has taken note of the seemingly recession-proof profitability potential of Medicaid-funded autism centers.
President Trump announced during last week’s State of the Union address that VP Vance would be heading up the administration’s “war on fraud.”
Quality Learning Center in Minnesota became an emblem of the Minnesota fraud, after allegations it was collecting funds but providing no services. It has since been closed.
In the last decade, private equity firms have acquired over 500 autism centers in the US, according to a January 2026 Brown University study.
Among them, Michigan-based Centria Healthcare LLC, a business which has distributed over half a billion in Medicaid reimbursements. It was acquired by private equity firm Thomas H. Lee Partners in 2019.
Indiana-based Hopebridge LLC, backed by PE firm Arsenal Capital Partners, has also taken in at least $140 million, according to the data.
“The increases you’re seeing in some states are astronomical,” Daniel Arnold, a health policy researcher at Brown University, told The Post.
“When private equity comes in, usually the price [of care] increases, the intensity of services increase as well. In the ABA space this would mean more hours at a higher price.”
Medicaid fraud has been a hot topic since it was revealed last fall that Somali scammers in Minnesota had bilked the state out of an estimated $9 billion in similar schemes.
“It’s not obvious to me that, say, 40 hours a week of ABA is better than 20. It gets to a point where you are crowding out other services kids are doing —like speech therapy, occupational therapy or play activities,” he added.
For those who are proven to have inflated bills, there are consequences.
Two executives at South Carolina Early Autism Project, Angela Breitweiser Keith and Ann Davis Eldridge, were sentenced to a year in prison in 2019 and paid $8.8 million in a settlement for using autism services to defraud Medicaid.
The Department of Justice said the execs had instructed employees to bill for time waiting in driveways and sitting in restaurants; pressured employees to submit exaggerated session timesheets; forged patient signatures and incentivized fraud by establishing high billing goals with rewards like gift cards and company-paid vacations for those who met quotas.
During last week’s State of the Union address, President Trump announced he was appointing Vice President JD Vance to lead a “war on fraud” task force.
“The gold standard solution would be to have some sort of set funding because right now Medicaid is an open-ended reimbursement,” said Medrano. “Have the state internalize the cost of Medicaid so they’re incentivized to save money.”
Sylvia Xu of The Epoch Times teases more conclusions out of the HHS-OIG audit of Colorado's state run Medicaid Applied Behavior Analysis for Children Diagnosed With Autism program:
100 Percent of Audited Medicaid Claims for Autism Care in Colorado Were Improper or Flawed: Report
Colorado Medicaid spending on Applied Behavior Analysis rose 280 percent in five years and suffers from a lack of oversight, according to the Inspector General.
By Sylvia Xu - March 5, 2026Colorado’s Medicaid program made an estimated $77.8 million in improper payments and another $207.4 million in potentially improper payments for autism therapy, according to a February report from the Inspector General for the Department of Health and Human Services.
Auditors investigated $289.5 million in Medicaid payments from 2022 to 2023 that paid for more than 1 million claims for Applied Behavior Analysis—a therapy used to treat autism and developmental disabilities.
Each of the 100 claims reviewed contained at least one improper or potentially improper payment, suggesting a 100 percent failure rate.
Improper payments are not necessarily fraudulent. Payments are considered improper when the claim does not meet federal or state requirements. Payments are potentially improper when the submitted claim is so poor or unreliable that auditors cannot verify that the services were provided correctly.
Claim Errors
In 93 of 100 claims examined, the billing providers either did not provide notes verifying that the therapy took place, didn’t provide the required signatures, or billed for more time than the notes indicated.
In 18 cases, the therapy that was supposed to be performed by a specialist—such as a Board Certified Behavior Analyst—was performed by staff without those qualifications.In seven cases, the children receiving therapy lacked a current doctor’s diagnosis or referral on file.
In 88 cases, facilities billed for recreational activities that are not considered medical therapy, such as academic tutoring, day care, or custodial care. In one case, a facility billed for children swimming and playing on water slides.
In 76 cases, facilities billed for a full eight-hour day without subtracting time for naps, meals, or breaks.
Oversight and Safety Concerns
The report concludes that Colorado made these improper payments because it did not provide effective oversight. The state did not regularly review Medicaid payments to catch errors and failed to give clear guidance to therapy centers on how to bill or what counts as therapy.
Additionally, the state didn’t properly check if its prior authorization contractors were following the rules when approving therapy for children.While the audit focused on money, it also uncovered problems that could affect the safety and quality of care.
Some staff members had criminal convictions for weapons offenses, assault, or driving under the influence. In one case, three staff members at a facility providing care to an 11-year-old child with autism had criminal histories.
A non-credentialed technician had a felony weapons offense conviction three months prior to treating children. A registered behavior technician had been convicted of misdemeanor assault and physical harassment, such as a strike, shove, or kick. Another behavior technician had an aggravated misdemeanor weapons conviction.
The state did not require background checks for these workers.
Previous Audits
The report comes as part of a series of seven Inspector General audits examining state Medicaid payments for autism therapy. Four are are complete and three remain in progress.
In previous audits, the agency estimated more than $120 million in improper payments and nearly $200 million in potential improper payments for Indiana, Wisconsin, and Maine.
The potential fraud, waste, and abuse in Medicaid autism therapy payments in Colorado was the highest among these audits.
The Office of Inspector General recommended that Colorado refund $42.6 million—the federal portion of the improper payments—to the federal government.
Also, the agency suggested that the state begin regular reviews of autism facilities to ensure they follow the rules and provide better training and guidance to facilities on documenting and billing for therapy.
The state of Colorado agreed to improve its guidance and conduct more regular reviews in the future, according to a statement. But it disagreed with the recommendation to refund the money, arguing that the audit derived its findings from a limited sample and didn’t have enough detail on the errors.
Further, Colorado argued that its Medicaid program does not require certification of behavior technicians before making payments, so the refund calculation based on this statute should be rescinded.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.


















